Search Results - Simigdala, N

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Abstract P1-09-03: Global knockdown of cellular kinases identifies MPS1 as a novel modulator of endocrine and palbociclib resistance highlighting a new role for MPS1 inhibitors

    Abstract P1-09-03: Global knockdown of cellular kinases identifies MPS1 as a novel modulator of endocrine and palbociclib resistance highlighting a new role for MPS1 inhibitors by Nikitorowicz-Buniak, J, Pancholi, S, Simigdala, N, Ribas, R, Linardopoulos, S, Dowsett, M, Johnston, SR, Martin, L-A

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Abstract P4-04-09: New oral SERD elacestrant (RAD1901) shows efficacy in breast cancer models harbouring ESR1 mutations and enhances the antiproliferative activity of mTORC1 and CDK4/6 inhibitors

    Abstract P4-04-09: New oral SERD elacestrant (RAD1901) shows efficacy in breast cancer models harbouring ESR1 mutations and enhances the antiproliferative activity of mTORC1 and CD... by Martin, L-A, Pancholi, S, Simigdala, N, Nikitorowicz-Buniak, J, Ribas, R, Garner, F, Bihani, T, Dowsett, M

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Abstract P3-03-09: Resistance to palbociclib depends on multiple targetable mechanisms highlighting the potential of drug holidays and drug switching to improve therapeutic outcome

    Abstract P3-03-09: Resistance to palbociclib depends on multiple targetable mechanisms highlighting the potential of drug holidays and drug switching to improve therapeutic outcome by Martin, L-A, Pancholi, S, Ribas, R, Gao, Q, Simigdala, N, Nikitorowicz-Buniak, J, Johnston, SR, Dowsett, M

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: